Search

everythinglearnresearchcommunity

for

Search:↓

The authors suggest a method for hair transplantation in fibrosing alopecia pattern distribution to improve treatment outcomes and cover bald areas.

A woman has a permanent hair loss condition treated with steroids and new medicines, but hair might not regrow.

Fibrosing alopecia in a pattern distribution is a new type of scarring hair loss that resembles common baldness and an autoimmune skin disease.

Lichen planopilaris causes permanent hair loss and scarring due to damage to hair follicles and can be mistaken for other hair loss conditions.

The trichoscopy-assisted hair pull test is useful for diagnosing different types of hair loss.

Graham-Little Piccardi Lassueur Syndrome is a rare skin condition with specific hair loss and skin symptoms.

Lichen planopilaris in men often affects the scalp, eyebrows, arms, legs, and beard, with many having family members with hair loss.

Trichoscopy helps tell apart Lichen planopilaris and Frontal fibrosing alopecia from other hair loss conditions.

Trichoscopy helps detect early complications in hair transplants and ensures quality in the procedure.

The authors concluded that PRP injections were not significantly effective for treating lichen planopilaris and its variants and should not be used as the only treatment.

Trichoscopy effectively helps diagnose different types of hair loss in women.

A young man with an unusual type of scarring hair loss suggests a possible new variant of a known scalp condition.

Hair follicle bumps with stem cells might contribute to permanent hair loss by getting disconnected due to scarring.

Two unusual cases showed that Lichen Planopilaris can look like other skin conditions and need early treatment to protect hair.

Isotretinoin at low doses effectively treats facial papules in frontal fibrosing alopecia.

Lichen planopilaris involves disrupted fat metabolism, increased scarring, and mast cell activity.

Trichoscopy helps effectively tell apart different types of patchy hair loss in Egyptian patients.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

Macrophages are more involved in Lichen planopilaris than in Frontal fibrosing alopecia.

Mitochondrial dysfunction may contribute to chronic inflammation and immune system issues in Lichen planopilaris.

A new treatment using AGED to modulate PPAR-γ shows promise for treating scarring hair loss by protecting and repairing hair follicle cells.

Naltrexone shows promise as a safe treatment for a type of hair loss called lichen planopilaris.

A woman's hair loss was correctly diagnosed as Lichen planopilaris after initial misdiagnosis, highlighting the usefulness of trichoscopy in diagnosing hair disorders.

Scarred skin in lichen planopilaris loses immune cells due to a decrease in a specific protein in skin cells.

N-acetyl-GED may help prevent and partially reverse a process that leads to scarring hair loss.

Women in Australia report different signs of facial aging compared to women in the US, UK, and Canada; men with Lichen planopilaris often have hormonal abnormalities and thyroid disease.

Most men with lichen planopilaris had it confirmed by biopsy and often had thyroid issues, sexual dysfunction, or prostate cancer, hinting at a link with hormonal problems.

Most patients with Lichen planopilaris improved with acitretin, but treatments often didn't work well; preventing infection in skin surgery is important, and bupivacaine might be a better anesthetic.

Sweat glands and hair follicles are determined by opposing signals, with BMPs promoting sweat glands and blocking BMPs leading to hair follicles.

Researchers improved a method to study individual cells in newborn mouse skin and found a way to assess the severity of a skin condition in humans.